Specialties
Reports that name this provider
- Stem Cell Therapy Quality in Spain
- Conducted Phase I/II clinical trial (NCT01700920) for autologous mesenchymal stem cell therapy in femoral head osteonecrosis with published long-term follow-up results (5+ years); trial included rigorous quality controls (viability >80%, flow-cytometric immunophenotyping, multilineage differentiation testing, karyotyping, mycoplasma testing)